Literature DB >> 6540144

Chemotherapy for advanced epidermoid carcinoma of the esophagus with single-agent cisplatin: final report on a Southwest Oncology Group study.

F J Panettiere, L P Leichman, E J Tilchen, T T Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6540144

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  7 in total

1.  Phase II Trial of Docetaxel and Carboplatin in Patients With Advanced Squamous Carcinoma of the Esophagus (E2298): A Trial of the Eastern Cooperative Oncology Group.

Authors:  Joanne F Rossman; Carla I Falkson; Ronghui Xu; Coenraad F Slabber; Bernard A Mason; Mary F Mulcahy; Al B Benson
Journal:  Gastrointest Cancer Res       Date:  2011-01

Review 2.  Combined modality therapy for esophageal cancer.

Authors:  Z Gamliel; M J Krasna
Journal:  Curr Oncol Rep       Date:  1999       Impact factor: 5.075

3.  Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.

Authors:  A Harstrick; C Bokemeyer; P Preusser; C H Köhne-Wömpner; H J Meyer; M Stahl; H Knipp; H J Schmoll; H Wilke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study.

Authors:  Susan G Urba; Kari Chansky; Peter J VanVeldhuizen; Robert E Pluenneke; Jacqueline K Benedetti; John S Macdonald; James L Abbruzzese
Journal:  Invest New Drugs       Date:  2004-01       Impact factor: 3.850

5.  BRCA1 mRNA expression as a predictive and prognostic marker in advanced esophageal squamous cell carcinoma treated with cisplatin- or docetaxel-based chemotherapy/chemoradiotherapy.

Authors:  Yong Gao; Jing Zhu; Xiaohui Zhang; Qingquan Wu; Shaoning Jiang; Yangqing Liu; Zhibin Hu; Baorui Liu; Xiaofei Chen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

6.  Cisplatin and etoposide in oesophageal cancer: a phase II study. Rotterdam Oesophageal Tumour Study Group.

Authors:  T C Kok; A Van der Gaast; J Dees; W M Eykenboom; H Van Overhagen; G Stoter; H W Tilanus; T A Splinter
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

Review 7.  Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview.

Authors:  Jalil Pirayesh Islamian; Mohsen Mohammadi; Behzad Baradaran
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.